Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
Pmsl. Not bottles he rapping together tho.... its pot noodles
And all those who turn up to roll have to wear sequined spandex monotards. Just saying
Stocktaker, there's absolutely no point coming on here crying about how much our mcap is and how much revenue we have generated. Not one single person on here will give you the answers you want to hear. If you look at our sp and the steady rise then I guess that the whole market disagrees with your opinion. Do yourself a favour and go and take a cold shower and have a word with yourself..... maybe have a word about buying into Avacta yeah. Gl with your decisions but please don't come back to let us know what you decide. No one on here is the slightest bit interest.
Doggy100s pants. Soiled them. Just saying. Lol
Thanks for clearing that up DP. Appreciate it.
Looks to me like we will find out with the trials later this year whether Affimers are the mutts nuts or not.
Am I reading this correctly that doxorubicin trials will be using affimers?
Avacta's tumour microenvironment activated drug conjugates (TMAC) are a ground-breaking new form of cancer immunotherapy, co-invented with Tufts University Medical School, combining Affimers with chemotherapies in a single drug using a linker that is designed to only release the chemotherapy in the tumour microenvironment. This allows extremely potent chemotherapies, too potent to be given to patients systemically, to be combined with Affimer immune-checkpoint therapies.
In order to test the TMAC linker in humans for the first time, a standard-of-care chemotherapy called doxorubicin has been modified with the linker rendering it inactive and harmless until the linker is cleaved in the tumour releasing active doxorubicin. Doxorubicin has well documented safety issues limiting its dosing, and also limiting the patient sub-group that can be treated. Despite these issues, the global doxorubicin market is valued at $910m and is expected to reach $1.4bn by the end of 2025[1]. Avacta's TMAC linker has been shown to increase the maximum tolerated dose of doxorubicin by a factor of six in a pre-clinical study in mice.
So little ever happens? If you're buy in is correct (3p) then you're on a 70 bagger already. Wtf do you want?
There are some very knowledgeable posters on this board who very kindly share their info for free which helps a lot of less informed people. I thank them for their efforts.
You on the other hand have offered what?
Feck off you twat.
Filtered
Hopefully just a 20m order and not a weekly order of 20m. Still doesn't bode well for us. Gutted is an understatement
Looks like that is the case ffs.
Thanks ES, appreciate that.
I just clicked on his twitter feed and a post came up saying that access is restricted due to unusual activity. If you want to proceed click this. I did but looks like posts have been removed unless I'm doing something wrong.
One thing's for Craptaun Twat, he was loved and admired by people who didn't know him.
You, you nasty pos, are probably loathed by your family as much as the people on here loathe you. Just feck off
Same feeling in my water......... but is probably cystitis.
136.98 just paid. About to break through PLs resistance level. Lol
Just go and take a running jump Ray. You're not invested and try your damndest to antagonise the board at every opportunity you get. If you were invested and done your research you wouldn't be such an ass hole.
Dazzlingdave, did I see you take on Rollerball Rocco in a sequined monotard at wrestlemania Hereford in the late 70s?
Just had a look and he is rambling all sorts. One thing he is definitely not and that is a mathmagician. He's doing sums over there and they are way out. I thought to help him out but then thought......... sod that, stay well clear.
I think I read that it was a permanent ban due to his shenanigans on another board.